LITERATURE REVIEW: PILIHAN TERAPI PASIEN ASMA DENGAN ATRIAL FIBRILASI

Rizki Putra Sanjaya, Sigit Pratama Iustitia Nasruddin, Diyan Ekawati, Hetti Rusmini, Wayan Ferly Aryana

Sari


Abstrak: Review Literatur: Pilihan Terapi Pasien Asma dengan Atrial
Fibrilasi. Asma memiliki dampak sistemik terkait dengan perkembangan
aterosklerosis dan modifikasi pada struktur dan fungsi pembuluh darah. Terapi asma
dengan bronkodilator dan kortikosteroid oral atau sistemik telah diidentifikasi sebagai
faktor risiko kejadian CVD dan stroke, sedangkan pemberian bronkodilator inhalasi
β2-agonis dapat meningkatkan risiko terjadinya fibrilasi atrium. Terapi asma
berdasarkan GINA, merekomendasikan pemberian antibodi anti-IgE yang merupakan
jenis terapi tipe controller asma, selain pemberian kortikosteroid oral, namun
terkendala keterbatasan obat dan harga obat yang jauh lebih mahal dibandingkan
golongan β2-agonis.


Kata Kunci


Terapi asma; Atrial fibrilasi; Antibodi anti-IgE

Teks Lengkap:

PDF

Referensi


Albanna AS, Atiah AK, Alamoudi SM, Khojah OM, Alajmi RS, & Dabroom AA. (2021). Treatment response among asthmatic patients with and without reversible airflow limitations. J Taibah Univ Med Sci.

https://doi.org/10.1016/j.jtumed.2021.07.005

Andika GA, Sukohar A, Yonata A. (2021). Tatalaksana Aritmia: Fibrilasi Atrial. Medical Journal of Lampung University, Vol.11(3), 247-252.

Cazzola M, Rogliani P, Calzetta L, Matera MG. Bronchodilators in subjects with asthma-related comorbidities. Respir Med. 151: 43–48. (2019)

Cazzola M, Hanania NA, Rogliani P, Matera MG. (2023) Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications. Kardiol Pol. 81(3):232-241.

https://doi.org/10.33963/KP.a2023.0038

Cepelis A. et al. (2018) Associations of Asthma and Asthma Control With Atrial Fibrillation Risk: Results From the Nord-Trøndelag Health Study (HUNT). JAMA Cardiol, 3(8), 721-728.

https://doi.org/10.1001/jamacardio.2018.1901

Corlateanu A, Covantev S, Mathioudakis AG, Botnaru V, Cazzola M, Siafakas N. (2018). Chronic obstructive pulmonary disease and stroke. COPD. PubMed. 15(4):405–413.

Corlateanu A, Stratan I, Covantev S, Botnaru V, Corlateanu O, Siafakas N. (2021). Asthma Research and Practice. BioMed Central 7:3.

Craig T. January, Chair, L. Samuel Wann, Vice Chair, & Hugh Calkins. (2019). Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons.

https://doi.org/10.1161/CIR.0000000000000665

European Society of Cardiology. (2020). ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS), European Heart Journal, Vol. 42(5): 507.

https://doi.org/10.1093/eurheartj/ehaa798

Fang Z-H, Li Z-F, An Z-Y, Huang S-C, Hao, & Zhang W-X. (2022) Meta-Analysis of the Association Between Asthma and the Risk of Stroke. Front. Neurol. 13:900438.

https://doi.org/ 10.3389/fneur.2022.900438

Global Strategy for Asthma Management and Prevention. (2022). Pocket guide for asthma managements and prevention (for adults and children older than 5 years). Vancouver: National Institutes of Health.

Heidenreich PA, Mark Estes NA, Fonarow GC, Jurgens CY, Kittleson MM, Marine JE, et al. (2021). Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. Circ Cardiovasc Qual Outcomes. 1;14(1):E000100.

Keramidas, G. Gourgoulianis, K.I. Kotsiou, O.S. (2021). Venous Thromboembolic Disease in Chronic Inflammatory Lung Diseases: Knowns and Unknowns. J. Clin. Med. 10: 2061.

https://doi.org/10.3390/jcm10102061

Muath Alobaida & Abdullah Alrumayh. (2021). Rate control strategies for atrial fibrillation, Annals of Medicine, 53:1, 682-692,

https://doi.org/ 10.1080/07853890.2021.1930137

Perhimpunan Dokter Paru Indonesia (PDPI). (2018). Program penatalaksanaan asma. Konsensus Asma.

Perhimpunan Dokter Paru Indonesia (PDPI). (2021). Asma Berat ; Pedoman Diagnosis dan Pentalaksanaan di Indonesia. Jakarta: Balai Penerbit FKUI.

Pilar Gallego, et al. (2021). Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial Fibrillation. AHA Journal. 5: 312-318.

https://doi.org/10.1161/CIRCEP.111.967000

Raita Y, Camargo CA, Faridi MK, Brown DFM, Shimada YJ, Hasegawa K. (2020). Risk of Acute Myocardial Infarction and Ischemic Stroke in Patients with Asthma Exacerbation: A Population-Based. Clin Immunol. 8(1):188–194. e8.

Verbiest-van Gurp, N., Uittenbogaart, S.B., Van de Moosdijk, S.C.M. et al. (2023) How is atrial fibrillation detected in everyday healthcare? Results of a Dutch cohort study. Neth Heart J, 31:76–82. https://doi.org/10.1007/s12471-022-01719-2

Zeiger R, Sullivan P, Chung Y, Kreindler JL, Zimmerman NM, Tkacz J. (2020). Systemic Corticosteroid-Related Complications and Costs in Adults with Persistent Asthma. J Allerg Clin Immunol. 8(10):3455–3465.e13.




DOI: https://doi.org/10.33024/jikk.v10i8.10200

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc4.footer##

Pendidikan Dokter Universitas Malahayati Lampung


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.